Skip to main content

Advertisement

Log in

Physical activity and health-related quality of life among postmenopausal women with breast cancer treated with aromatase inhibitors

  • Original Article
  • Published:
Supportive Care in Cancer Aims and scope Submit manuscript

Abstract

Purpose

Breast cancer is the most common non-cutaneous cancer in women with an estimated 268,600 new cases diagnosed in 2019, joining the over 3 million women living with the disease. To reduce cancer recurrence, postmenopausal women (highest incidence and prevalence of breast cancer) who test positive for hormone receptors in their tumors are candidates for adjuvant endocrine therapy (i.e., aromatase inhibitors [AIs]). Despite the benefits of AIs in the treatment for breast cancer, many women remain at risk for complications, including osteoporosis and fractures, all of which can adversely affect health-related quality of life (HRQoL). Increased attention is being paid to the role physical activity (PA) may have in improving health outcomes in survivors of breast cancer, but few studies focus on postmenopausal women. We sought to examine (1) the percentage of women in our sample meeting (or not meeting) the American College of Sports Medicine (ACSM) PA recommendations, (2) the relationship between AI use and three types of PA (leisure time, strength training, and walking), and (3) the relationship between PA and HRQoL by AI use, controlling for covariates.

Methods

Postmenopausal women with breast cancer (n = 170), ages 50–95 years (M = 68.7), diagnosed with stage 1–3 disease, 45% on AIs, were recruited. Demographic, HRQoL, and PA data were collected via patient self-report, while clinical data (AI use) were abstracted from patient medical records. To address study aims, we utilized descriptive statistics, chi-square analyses, and multiple linear regressions, respectively.

Results

Half of the sample met the ACSM recommendations for total leisure-time PA (vigorous and moderate intensity combined), and 65.3% (n = 111) weekly walking. With regard to strength training, 36.5% of the women met these ACSM recommendations. Generally, there were positive relationships between AI use and most HRQoL domains. There were no statistically significant relationships between PA (meeting recommendations or not) and HRQoL by AI use.

Conclusion

The proportion of women meeting guidelines for walking activity was encouraging. It is imperative that healthcare professionals providing care to breast cancer survivors follow up regarding symptoms, side effects, and physical activity in tandem to fully understand their relationship on an individual level.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

Data availability

The data and materials are available if requested.

References

  1. National Cancer Institute (NCI) (2019) Cancer stat facts: Common cancer sites. National Cancer Institute (NCI), Bethesda https://seer.cancer.gov/statfacts/html/common.html

    Google Scholar 

  2. American Cancer Society (ACS) (2017) How common is breast cancer?. https://www.cancer.org/cancer/breast-cancer/about/how-common-is-breast-cancer.html

  3. Centers for Disease Control and Prevention (CDC) (2016) What are the risk factors for breast cancer? https://www.cdc.gov/cancer/breast/basic_info/risk_factors.htm

  4. Anders A, Johnson CK, Litton R, Phillips J, Bleyer M (2009) Breast cancer before age 40 years Semin. Oncol 36:237–249

    Google Scholar 

  5. Howlader CK, Noone N, Krapcho AM, Neyman M, Aminou N, Waldron R, Altekruse W, Kosary SF, Ruhl CL, Tatalovich J, Cho Z, Mariotto H, Eisner A, Lewis MP, Chen DR, Feuer HS, SEER Cancer Statistics Review, 1975-2009 (Vintage 2009 Populations) (2012). National Cancer Institute, Bethesda

  6. DeSantis A, Fedewa CE, Sauer SA, Kramer AG, Smith JL, Jemal RA (2015) Breast cancer statistics, 2015: convergence of incidence rates between black and white women. CA Cancer J Clin 66:31–42

    Article  Google Scholar 

  7. McPherson JM, Steel K, Dixon CM (2000) Breast cancer - epidemiology, risk factors, and genetics. Br Med J 321:624–628

    Article  CAS  Google Scholar 

  8. Cella LJ, Fallowfield D (2008) Recognition and management of treatment-related side effects for breast cancer patients receiving adjuvant endocrine therapy. Breast Cancer Res Treat 107:167–180

    Article  CAS  Google Scholar 

  9. Chen RT, Maricic Z, Aragaki M, Mouton AK, Arendell C, Lopez L, Chlebowski AM (2009) Fracture risk increases after diagnosis of breast cancer or other cancers in postmenopausal women: results from the Women’s Health Initiative. Osteoporos Int 20:527–536

    Article  CAS  Google Scholar 

  10. Choski C, Williams P, Clark M, Van Poznak PM, (2013) Skeletal manifestations of treatment of breast cancer Curr Osteoporos Rep. 11:319–328.

  11. Taxel P, Choski C, Van Poznak P (2012) The management of osteoporosis in breast cancer survivors. Maturitas 73:275–279

    Article  Google Scholar 

  12. Bellizzi KM, Rowland DD, Jeffrey JH (2005) Current health behaviors of cancer survivors: examining opportunities for cancer control intervention. J Clin Oncol 23:8884–8893

    Article  Google Scholar 

  13. Green EL, Steinnagel HJ, Morris G, Laasko G (2014) Health behavior models and patient preferences regarding nutrition and physical activity after breast or prostate cancer diagnosis. Eur J Cancer 23:640–652

    Article  CAS  Google Scholar 

  14. American College of Sports Medicine (ACSM) (2018) ACSM’s guidelines for exercising testing and prescription, 10th edn. American College of Sports Medicine, Indianapolis

    Google Scholar 

  15. Brown JA, Ligibel JC (2019) Putting exercise into oncology practice: state-of-the- science, innovation, and future directions. Cancer J 25:316–319

    Article  Google Scholar 

  16. Sallis MF, Hovell JF (1990) Determinants of exercise behavior Exerc. Sport Sci Rev 18:301–330

    Google Scholar 

  17. Files S, Ko JA, Pruthi MG (2010) Managing aromatase inhibitors in breast cancer survivors: not just for oncologists. Mayo Clin Proc 85:560–566

    Article  Google Scholar 

  18. Irwin ML, McTiernan A, Bernstein L, Gilliland FD, Baumgartner R, Baumgartner K, Ballard-Barbash R (2004) Physical activity levels among breast cancer survivors. Med Sci Sports Exerc 36:1096–1108

    Google Scholar 

  19. McNeely KS, Campbell ML, Rowe KL, Klassen BH, Mackey TP, Courneya JR (2006) Effects of exercise on breast cancer patients and survivors: a systematic review and meta-analysis. Can Med Assoc J 175:34–41

    Article  Google Scholar 

  20. Zeng WKW, Huang Y, Cheng M, Zhou ASK, So Y (2014) Meta-analysis of the effects of exercise intervention on quality of life in breast cancer survivors. Breast Cancer 21:262–274

    Article  Google Scholar 

  21. Campbell C, Winters-Stone KL, Wiskemann KM, May J, Schwartz AM, Zucker KHKS, Matthews DS, Ligibel CE, Gerber JA, Morris LH, Patel GS, Hue AV, Perna TF, Schmitz FM (2019) Exercise guidelines for cancer survivors: consensus statement from international multidisciplinary roundtable. Med Sci Sports Exerc 51:2375–2390

    Article  Google Scholar 

  22. Judge G, Kleppinger JO, Kenny A, Smith A, Biskup JA, Marcella B (2005) Home- based resistance training improves femoral bone mineral density in women on hormone therapy. Osteoporosis 16:1096–1108

    Article  Google Scholar 

  23. Nyrop LF, Muss KA, Hackney H, Clevalend B, Callahan R (2014) Joint pain and physical activity among breast cancer survivors on aromatase inhibitor therapy. J Clin Oncol 32:15

    Article  Google Scholar 

  24. Winters-Stone KM, Dobek A, Nail J, Bennett L, Leo JA, Naik MC, Schwartz A (2011) Strength training stops bone loss and builds muscle in postmenopausal breast cancer survivors: a randomized, controlled trial. Breast Cancer Res Treat 127:447

    Article  Google Scholar 

  25. Hadji P (2015) Cancer treatment-induced bone loss in women with breast cancer. Bonekey Rep 4:1–43

    Article  CAS  Google Scholar 

  26. Avis J, Crawford NE, Manuel S (2005) Quality of life among younger women with breast cancer. J Clin Oncol 23:3322–3330

    Article  Google Scholar 

  27. Victorson D, Barocas D, Song J, Cella J (2008) Reliability across studies from the functional assessment of cancer therapy-general (FACT-G) and its subscales: a reliability generalization. Qual Life Res 17:1137–1146

    Article  Google Scholar 

  28. National Center for Health Statistics (2016) National health and nutrition examination survey (NHANES) https://wwwn.cdc.gov/Nchs/Nhanes/continuousnhanes/default.aspx? BeginYear=2015

  29. Pinto M, Dunsiger BM, Waldemore S (2013) Physical activity and psychosocial benefits among breast cancer patients. Psychooncology 22:2193–2199

    Article  Google Scholar 

  30. HealthyPeople.gov (2020) Physical activity, https://www.healthypeople.gov/2020/data-search/Search-the-Data#topic-area=3504

  31. Thomas E, Cartmel GA, Harrigan B, Fiellin M, Capozza M, Zhou S, Ercolano Y, Gross ML, Hershman CP, Ligibel D, Schmitz J, Li K, Sanft T, Irwin SY (2017) The effect of exercise on body composition and bone mineral density in breast cancer survivors taking aromatase inhibitors. Obesity 25:346–351

    Article  CAS  Google Scholar 

  32. Centers for Disease Control and Prevention (CDC) (2008) US Department of Health and Human Services physical activity guidelines for Americans 2008, Washington, DC.

  33. de Groef D, Geraerts A, Demeyer I, Van der Gucht H, Dams E, de Kinkelder L, van Althuis CN, Van Kampen S, Devoogdt M (2018) Physical activity levels after treatment for breast cancer: two-year follow-up. Breast 40:23–28

    Article  Google Scholar 

  34. Yan AV, Wang AF, Ng Y (2018) Physical activity and annual medical outlay in U.S. colorectal, breast, and prostate cancer survivors. Prev Med Rep 9:118–123

    Article  Google Scholar 

  35. Farias B, Ornelas AJ, Hohl IJ, Zeliadt SD, Hansen SB, Li RN, Thompson CI (2016) Exploring the role of physician communication about adjuvant endocrine therapy among breast cancer patients on active treatment: a qualitative analysis. Support Care Cancer 25:75–83

    Article  Google Scholar 

  36. Bellizzi KM, Smith A, Schmidt S, Keegan TH, Zebrack B, Lynch CF, Deapen D, Shnorhavorian M, Tompkins BJ, Simon M, Adolescent and Young Adult Health Outcomes and Patient Experience (AYA HOPE) Study Collaborative Group (2012) Positive and negative psychosocial impact of being diagnosed with cancer as an adolescent or young adult. Cancer 118:5155–5162

    Article  Google Scholar 

  37. Goss PE, Ingle JN, Pritchard KI, Robert NJ, Muss H, Gralow J, Gelmon K, Whelan T, Strasser-Weippl K, Rubin S, Sturtz K, Wolff AC, Winer E, Hudis C, Stopeck A, Beck JT, Kaur JS, Whelan K, Tu D, Parulekar WR (2016) Extending aromatase-inhibitor adjuvant therapy to 10 years. N Engl J Med 375:209–219

    Article  CAS  Google Scholar 

  38. Courneya DC, Segal KS, Mackey RJ, Gelmon JR, McKenzie K (2007) Effects of the aerobic and resistance exercise in breast cancer patients receiving adjuvant chemotherapy: a multicenter randomized controlled trial. J Clin Oncol 25:4396–4404

    Article  Google Scholar 

Download references

Acknowledgments

The authors would like to acknowledge the funding organization of the University of Connecticut’s InCHIP as well as the participants of the current study.

Funding

The research of the current study was funded by an internal seed grant from the University of Connecticut’s Institute for Collaboration on Health, Intervention, and Policy (InCHIP).

Author information

Authors and Affiliations

Authors

Contributions

All authors listed have actively participated in composition, editing, and review of the current manuscript.

Corresponding author

Correspondence to K. E. Dibble.

Ethics declarations

The study was performed with the approval of the Institutional Review Boards of UConn Health and the University of Connecticut (UConn) Storrs (the main campus of the public research university located in Storrs, CT).

Conflict of interest

The authors declare that they have no conflict of interest.

Code availability

N/A.

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Dibble, K.E., Bellizzi, K.M., Taxel, P. et al. Physical activity and health-related quality of life among postmenopausal women with breast cancer treated with aromatase inhibitors. Support Care Cancer 29, 2385–2394 (2021). https://doi.org/10.1007/s00520-020-05741-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00520-020-05741-1

Keywords

Navigation